Pharming’s APDS drug scores EU orphan status by Lucy Parsons | Oct 22, 2020 | News | 0 European commission grants leniolisib orphan drug designation Read More
Setback for Pharming’s bid to expand use of Ruconest by Selina McKee | Sep 20, 2018 | News | 0 US regulators have turned down Pharming’s application to expand the approved uses of Ruconest to include prophylaxis in patients with hereditary angioedema (HAE). Read More